Transporter-dependent cytotoxicity of antiviral drugs in primary cultures of human proximal tubular cells

被引:10
作者
Lash, Lawrence H. [1 ]
Lee, Caroline A. [2 ]
Wilker, Clynn [2 ,3 ]
Shah, Vishal [2 ,4 ]
机构
[1] Wayne State Univ, Sch Med, Dept Pharmacol, 540 East Canfield Ave, Detroit, MI 48201 USA
[2] Ardea Biosci, San Diego, CA 92121 USA
[3] Heron Therapeut, 12707 High Bluff Dr,Suite 200, San Diego, CA 92130 USA
[4] Organovo Holdings Inc, 6275 Nancy Ridge Dr,Suite 110, San Diego, CA 92121 USA
关键词
Antiviral drugs; Nephrotoxicity; Human proximal tubular cells; Biomarkers; Membrane transport; TENOFOVIR DISOPROXIL FUMARATE; HIV-INFECTED PATIENTS; INDUCED TOXICITY; CIDOFOVIR; NEPHROTOXICITY; PHARMACOKINETICS; EXPRESSION; ADEFOVIR; KIDNEY; SAFETY;
D O I
10.1016/j.tox.2018.05.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The role of plasma membrane transporters in the nephrotoxicity of two antiretroviral drugs, cidofovir and tenofovir, was studied in primary cultures of human proximal tubular (hPT) cells. Cells were grown on Transwell filter inserts to maintain epithelial polarity and access to either the apical or basolateral plasma membrane. The function of relevant membrane transporters, organic anion transporter 1 and 3 (OAT1/3), P-glycoprotein (multidrug resistance protein-1; P-gp or MDR1), and organic cation transporter 2 (OCT2), was validated by measurements of apical-to-basolateral and basolateral-to-apical fluxes of furosemide, digoxin, and metformin, respectively. Acute cytotoxicity of cidofovir (0, 10, 50, 150, or 300 mu M) in the absence or presence of 500 mu M probenecid, tenofovir disoproxil fumarate (0, 20, 90, 180, or 360 mu M) in the absence or presence of 500 mu M probenecid, or cisplatin (0, 20, 90, 180, or 360 mu M) as a positive control in the absence or presence of 500 mu M cimetidine, was assessed after 4-h incubations by determinations of release of lactate dehydrogenase (LDH), gamma-glutamyltransferase (GGT), N-acetyl-beta-D-glucosaminidase (NAG), or Kidney Injury Molecule(-1) (KIM-1). Cell death generally agreed with each of the four biomarkers, was generally greater when cidofovir or tenofovir was added to the upper compartment, and was markedly diminished in the presence of the appropriate transport inhibitor. Additionally, the extent of cytotoxicity caused by the two antiviral drugs was similar to that caused by cisplatin. The results demonstrate the importance of plasma membrane transport of antiviral drugs to elicit cytotoxicity in the hPT cell.
引用
收藏
页码:10 / 24
页数:15
相关论文
共 41 条
[1]  
Aloy B, 2016, AIDS REV, V18, P184
[2]  
[Anonymous], 1997, AM J HEALTH-SYST PH, V54, P12
[3]  
Araya CE, 2008, PEDIATR TRANSPLANT, V12, P790, DOI 10.1111/j.1399-3046.2008.00937.x
[4]   Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs [J].
Cihlar, T ;
Ho, ES ;
Lin, DC ;
Mulato, AS .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2001, 20 (4-7) :641-648
[5]   Novel Nucleotide Human Immunodeficiency Virus Reverse Transcriptase Inhibitor GS-9148 with a Low Nephrotoxic Potential: Characterization of Renal Transport and Accumulation [J].
Cihlar, Tomas ;
LaFlamme, Genevieve ;
Fisher, Robyn ;
Carey, Anne C. ;
Vela, Jennifer E. ;
Mackman, Richard ;
Ray, Adrian S. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (01) :150-156
[6]   Cidofovir: clinical experience and future perspectives on an acyclic nucleoside phosphonate analog of cytosine in the treatment of refractory and premalignant HPV-associated anal lesions [J].
Coremans, Georges ;
Snoeck, Robert .
EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (08) :1343-1352
[7]  
Cummings BS, 2000, J PHARMACOL EXP THER, V293, P677
[8]   Metabolism and toxicity of trichloroethylene and S-(1,2-dichlorovinyl)-L-cysteine in freshly isolated human proximal tubular cells [J].
Cummings, BS ;
Lash, LH .
TOXICOLOGICAL SCIENCES, 2000, 53 (02) :458-466
[9]  
Cundy KC, 1996, DRUG METAB DISPOS, V24, P738
[10]   Tenofovir-related nephrotoxicity: An ongoing clinical challenge [J].
Foisy, Michelle M. ;
Hughes, Christine ;
Hills-Nieminen, Cara ;
Singh, Ameeta E. ;
Joffe, A. Mark .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (15) :1272-1274